EnglishThe Hsp90 chaperone is a promising target for the treatment of cancer. Well known inhibitors, e.g. geldanamycin, radicicol, novobiocin and their derivatives, have been extensively investigated and optimized as inhibitors of Hsp90. More recently, new chemotypes of natural origin were reported to modulate Hsp90 function via various and often “non-conventional” mechanisms. This review focuses on these novel classes of natural products whose structures have not yet been thoroughly explored for medicinal chemistry purposes. These novel chemotypes may constitute interesting starting points for future drug discovery campaigns.
Novel and less explored chemotypes of natural origin for the inhibition of Hsp90 / Pellati, Federica; Rastelli, Giulio. - In: MEDCHEMCOMM. - ISSN 2040-2503. - STAMPA. - 7(2016), pp. 2063-2075. [10.1039/c6md00340k]
| Data di pubblicazione: | 2016 | |
| Titolo: | Novel and less explored chemotypes of natural origin for the inhibition of Hsp90 | |
| Autore/i: | Pellati, Federica; Rastelli, Giulio | |
| Autore/i UNIMORE: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1039/c6md00340k | |
| Rivista: | ||
| Volume: | 7 | |
| Pagina iniziale: | 2063 | |
| Pagina finale: | 2075 | |
| Codice identificativo ISI: | WOS:000390551700002 | |
| Codice identificativo Scopus: | 2-s2.0-84994480336 | |
| Citazione: | Novel and less explored chemotypes of natural origin for the inhibition of Hsp90 / Pellati, Federica; Rastelli, Giulio. - In: MEDCHEMCOMM. - ISSN 2040-2503. - STAMPA. - 7(2016), pp. 2063-2075. [10.1039/c6md00340k] | |
| Tipologia | Articolo su rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | |
|---|---|---|---|
| Review_Novel_less_explored_chemotypes_natural_Hsp90_Pellati_Rastelli.pdf | Versione dell'editore (versione pubblicata) | Administrator Richiedi una copia |
Pubblicazioni consigliate
http://hdl.handle.net/11380/1111528
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
Copyright © 2022